As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
神灯vp安全性
Jeroen Hoozemans, Amsterdam University Medical Centers, The Netherlands
Jason Huse, 加速器下载_加速器手机版_最新加速器安卓版下载:2021-9-2 · PP助手为您提供最新加速器下载，加速器安卓手机版免费下载，PP助手让你尽享好玩的手机应用 软件分类 游戏分类 影音播放 视频/音乐/铃声 系统工具 Wifi/安全/省电 通讯社交
神灯vp安全性
PP加速器怎么用的啊？_百度知道:2021-12-27 · PP加速器就是一个视频加速器而已.他支持好多网站的视频加速,其实这个东西有跟没有都差不多 已赞过 已踩过 你对这个回答的评价是？ 评论 收起 匿名用户 2021-12-27 展开全部 官方的PPlive安装程序是.exe格式的，官方的网页插件也是.exe格式的，并且 ... (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques
神灯vp安全性
We are excited to announce an open call for papers focusing on clinical, basic science, and translational studies that address current problems and knowledge gaps in TBI, which affects over 65 million people worldwide each year.
【uu换肤助手】UU换肤助手 9.20-ZOL软件下载:2021-11-22 · UU换肤助手是一款功能强大的英雄联盟uu换肤工具,使用这款uu换肤助手可伍让玩家朋友伊在玩英雄联盟的时候体验到不曾拥有的皮肤快感,马上下载这款免费的uu换肤助手吧。
More information on scope and submission can be found here.
神灯vp安全性
- No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
- pp加速器手机版: group of editors selected on the basis of their insightful, dedicated and prompt service
- pp加速器手机官方版publication within 2 months of submission
- Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
- Open access: enabling it to be read by a much larger set of readers, increasing its visibility
- Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees
神灯vp安全性
- Recent
- Most accessed
-
BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy
-
pp加速器官网网页
-
Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer’s-like mouse models
-
Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids
-
Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function
Most recent articles RSS
View all articles
-
Myelin alters the inflammatory phenotype of macrophages by activating PPARs
-
蚂蚁app加速器
-
Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice
-
The prion hypothesis in Parkinson's disease: Braak to the future
-
Neuropathology of brain and spinal malformations in a case of monosomy 1p36
tap加速器下载
View all articles
神灯vp安全性
ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.
pp加速器免费正式版下载
神灯vp安全性
The microbiota-gut-brain axis
Cross-journal collection
Low Grade Neuroepithelial Neoplasms
Thematic series
pp加速器
Thematic series
腾讯手游加速器电脑版下载_腾讯手游加速器电脑版官方下载「 ...:2021-1-2 · 腾讯手游加速器电脑版是一款工具类的软件，它是一款由腾讯游戏开发的电竞级移动游戏加速器，目前腾讯手游加速器手机版正在内测进行中，内测 ...
神灯vp安全性
Real-time quaking-induced conversion assay (RT-QuIC) has established itself as a powerful diagnostic tool for sporadic Creutzfeldt-Jakob disease. Can it accurately discriminate between and diagnose other neurodegenerative diseases?
Read Niccolò Candelise et al.'s full review here.
pp加速器官网网页
"The unique combination of human neuropathology with relevant experimental models is essential for understanding the pathogenesis of neurological diseases. Acta Neuropathologica Communications provides a platform for studies that centrally involve human neuropathology and bring new insight in disease mechanisms of neurological diseases using relevant experimental models. We welcome high quality papers that do not require major revisions, resulting in short turn-around times and fast publication. We hope you enjoy Acta Neuropathologica Communications and are looking forward to receive your submissions."
Jeroen Hoozemans, co-Editor-in-Chief, ANC
"As an original member of the ANC editorial board, it has been a pleasure to witness the growth and maturation of this journal first hand. ANC now occupies a well-defined niche for the rapid publication of high-quality work advancing the broad spectrum of neuropathology and its allied sciences. I look forward to receiving and evaluating your compelling manuscripts in the months and years ahead."
Jason T. Huse, co-Editor-in-Chief, ANC
Advertisement
Submit manuscript
- Editorial Board
- Instructions for Editors
- Frequently Asked Questions
- Sign up for article alerts and news from this journal
Follow
pp加速器安卓版下载
-
Speed
24 days to first decision for reviewed manuscripts only
13 days to first decision for all manuscripts
37 days from submission to acceptance
23 days from acceptance to publicationCitation Impact
6.270 - 2-Year impact factor
6.142 - 5-Year impact factor
1.331 - Source Normalized Impact per Paper (SNIP)
2.845 - SCImago Journal Rank (SJR)Usage
608,006 downloads
1,581 altmetric mentions -
More about our metrics
Advertisement
